This included increased numbers of CD4+ and CD8+ T cells, a higher proportion of effector T cells (such as CD8+ T cells secreting IFN-γ) in the tumor, and an increase in antigen-presenting cells (such as CD11c+ dendritic cells). This evidence concerns the gene CD8A and neoplasm.